Press Releases Year None201920182017201620152014 Entasis Appoints Robin David Isaacs as Chief Medical Officer Jul 15, 2015 Entasis Debuts with a Portfolio of Drug Candidates to Treat Serious Drug-resistant Bacterial Infections Jul 01, 2015 AstraZeneca to create stand-alone company for small molecule early stage antibiotic R&D Feb 26, 2015 ETX0914 (AZD0914) designated a Qualified Infectious Disease Product (QIDP) and given Fast Track status by US FDA Jun 03, 2014 Pagination First page « first Previous page ‹ previous Page 1 Page 2 Page 3 Page 4 Current page 5 Displaying 41 - 44 of 44
Entasis Debuts with a Portfolio of Drug Candidates to Treat Serious Drug-resistant Bacterial Infections Jul 01, 2015
ETX0914 (AZD0914) designated a Qualified Infectious Disease Product (QIDP) and given Fast Track status by US FDA Jun 03, 2014
